PAX3 Visualization (SV Type: Deletion)
The purpose of this report is to provide detailed information regarding regarding the influence of PAX3 gene on limbs phenotype by using POSTRE web app.
I uploaded POSTRE to shinyapps.io. Please use the following link to access to POSTRE web app: https://hhu66.shinyapps.io/postre_app/
Review of POSTRE workflow
User input: Chromosome number, coordinates of the SVs, patient’s phenotype
Software Internal Procedure:
Selecting cell types/tissues relevant to the patient’s phenotype
Loading of specific genomic data for each selected cell type/tissue from multiple sources*
Mapping SV Breakpoints in the context of TADs by using multiple sources* and selecting all the candidate genes located within the affected TADs
Calculating PS score for each candidate gene and assigning causative gene with the highest PS score
*All genomic data resources corresponding to each cell type/tissue are indicated at Supplementary_Data_1
Visualization by using UCSC Genome Browser: User can also visualize disease-relevant genomic data within the affected locus
Table1_LongRange_SVs (PAX 3 Example from Patient_Nr4)
| chr_Break1 | coord_Break1 | chr_Break2 | coord_Break2 | TypeSV | Phenotype | SV unique identifier |
|---|---|---|---|---|---|---|
| chr2 | 221278232 | chr2 | 223014332 | Deletion | limbs | Patient_Nr4 |
Input SV information
Results Overview
5 candidate genes (genes located between the breakpoint 1 and breakpoint 2)
PAX3 has shown the highest Pathogenic Scores of 0.98
Detailed Pathogenic Scores of each candidate gene
EmbryonicLimb1 = Embryonic Lower Limb
EmbryonicLimb2 = Embryonic Upper Limb
Graphical Abstract
Gene Impact - Regulatory Landscape Changes
PAX3 sequence is not directly affected by the SV -> Long range Mechanism
In the control, PAX3 has no enhancer nor enhancer activity
In patient, gained 6 enhancers and increased enhancer activity -> Gain of function
Gene Susceptibility to Gain of Function
Low expression (1FPKM < 7.3FPKM < 10FPKM)
Dosage sensitive gene (DS score = 0.95), implying the changes in gene copy number significantly contribute to the associated phenotype
Developmental gene (PcG score = 1). Polycomb domain proteins are controlling developmental genes from activating until the right time. The higher the score, the more likely the gene belongs to developmental gene category.
UCSC Genome Browser on Human (Reference genome: hg19)
All the genes involved in the affected TADs are candidate genes
Affected TADs positions: chr2:220440001-222880000, chr2:222880001-223520000
Visualized Affected Regulatory Domain (Patient_Nr4 case)
PAX3: Homo sapiens paired box 3 (PAX3), transcript variant PAX3D, mRNA.
Transcript (Including UTRs)
Position: hg19 chr2:223,064,606-223,163,715 Size: 99,110 Strand: -Coding Region
Position: hg19 chr2:223,065,893-223,163,334 Size: 97,442 Coding Exon Count: 10
EPHA4: Homo sapiens EPH receptor A4 (EPHA4), mRNA.
Transcript (Including UTRs)
Position: hg19 chr2:222,289,929-222,437,001 Size: 147,073 Total Exon Count: 17 Strand: -Coding Region
Position: hg19 chr2:222,291,180-222,436,968 Size: 145,789 Coding Exon Count: 16
SGPP2: Homo sapiens sphingosine-1-phosphate phosphatase 2 (SGPP2), mRNA.
Transcript (Including UTRs)
Position: hg19 chr2:223,289,322-223,423,617 Size: 134,296 Total Exon Count: 6 Strand: +Coding Region
Position: hg19 chr2:223,386,492-223,423,617 Size: 37,126 Coding Exon Count: 3
STK11IP: Homo sapiens serine/threonine kinase 11 interacting protein (STK11IP), mRNA.
Transcript (Including UTRs)
Position: hg19 chr2:220,462,596-220,471,260 Size: 8,665 Total Exon Count: 10 Strand: +Coding Region
Position: hg19 chr2:220,462,842-220,471,135 Size: 8,294 Coding Exon Count: 9
SLC4A3: Homo sapiens solute carrier family 4, anion exchanger, member 3 (SLC4A3), transcript variant 2, mRNA.
Transcript (Including UTRs)
Position: hg19 chr2:220,492,292-220,506,702 Size: 14,411 Total Exon Count: 23 Strand: +Coding Region
Position: hg19 chr2:220,492,715-220,506,450 Size: 13,736 Coding Exon Count: 22